LEXICON PHARMACEUTICALS, INC. Quotes Lexicon Pharmaceuticals, Inc. BOERSE MUENCHEN
Equities
LX31
US5288723027
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.71 EUR | +3.23% |
|
-.--% | -14.52% |
| 07-08 | Lexicon Pharmaceuticals Names Mike Exton CEO, Jeff Wade Operating Chief | MT |
| 07-08 | Lexicon Pharmaceuticals, Inc. Announces Appointment of Mike Exton, Ph.D. as Chief Executive Officer | CI |
Performance
| 1 day | +3.23% | ||
| Current month | -14.52% | ||
| Current year | -14.52% | ||
| 3 years | +21.24% | ||
| 5 years | +106.17% |
Volumes
marketsDaily volume
1 500
Estimated daily volume
1 500
Record volume 1
3 001
Record volume 2
2 000
Record volume 3
2 000
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
715 754 744
Capitalization (USD)
715 754 744
Net sales (USD)
1 204 000
Number of employees
285
Sales / Employee (USD)
4 225
Free-Float
98.44 %
Free-Float capitalization (EUR)
770 130 062
Free-Float capitalization (USD)
707 443 785
Highs and lows
3 years
2.80
4.34
5 years
0.897.08
10 years
0.8915.66
Indicators
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +3.23% | -.--% | -14.52% | - | 716M | ||
| -0.69% | +2.99% | +20.12% | +38.56% | 126B | ||
| +1.83% | +6.36% | +25.25% | +53.10% | 119B | ||
| +0.33% | +7.10% | +25.56% | +29.13% | 27.95B | ||
| +0.30% | +6.07% | -19.51% | -21.52% | 20.5B | ||
| +2.64% | +5.16% | -14.36% | -29.70% | 17.12B | ||
| +1.11% | +3.49% | -15.63% | -22.49% | 16.1B | ||
| -0.05% | +2.05% | -46.67% | -42.65% | 14.97B | ||
| +0.63% | +6.00% | +11.89% | +55.00% | 14.84B | ||
| 0.00% | +0.25% | +57.74% | +41.06% | 14.38B | ||
| -0.42% | +9.59% | +147.53% | +272.38% | 12.37B | ||
| +12.10% | +17.43% | -9.64% | -21.72% | 9.91B | ||
| -0.32% | -2.58% | +147.72% | +292.07% | 9.55B | ||
| +0.52% | +5.91% | +31.19% | +65.98% | 8.96B | ||
| +1.75% | +1.67% | +9.63% | +59.57% | 7.92B | ||
| -1.80% | -1.59% | -4.93% | +33.57% | 7.34B | ||
| Average | +1.32% | +4.87% | +21.96% | +53.49% | ||
| Weighted average by Cap. | +0.79% | +4.91% | +21.31% | +43.79% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2021 | +67.12% | ||
| 2020 | -51.55% | ||
| 2019 | -1.47% | ||
| 2018 | -36.34% | ||
| 2017 | -40.40% |
- Stock Market
- Equities
- LXRX Stock
- LX31 Stock
- Quotes Lexicon Pharmaceuticals, Inc.
